Shine-On BioMedical
  • LANGUAGE
    • 繁體中文
    • English
  • ABOUT
    • Overview
    • Milestone
    • Mission
    • Organization
    • Management and consulting team
  • Core Technologies
    • Targeted exosome for drug delivery
    • Trispecific T cell engager antibody
  • R&D Pipeline
    • Targeted exosome for drug delivery
      • SOB100: HLA-G targeted exosome (αHLA-G exo)
      • SOB101: HLA-G targeted exosomal doxorubicin
      • SOB102: HLA-G targeted exosomal microRNA
      • SOB201: Genetically engineered stem cell-derived exosomes
    • Trispecific T cell engager antibody
      • SOA101: Nanobody-based trispecific antibody T cell engager (Nb-TriTE)
      • SOA201: EphA10-trispecific immune cell engager antibody
    • Exosome-derived products
      • SOC101&SOC102
    • Products Pipeline
  • News
  • Links
    • 政府機構
    • 學術機構
    • 產業新知
  • Investor Zone
  • Sustainable development CSR
    • Sustainable development CSR
    • Ethics compliance and whistleblower protection
  • Stakeholders Area
  • Contact
  • Disclaimer
  • Terms
  • Privacy

Links

  1. HOME
  2. Links
Links
  • 政府機構
  • 學術機構
  • 產業新知
  1. Links
  • 財團法人國家生技醫療產業策進會

    財團法人國家生技醫療產業策進會
  • 環球生技月刊

    環球生技月刊
  • 中央研究院

    中央研究院
  • 財團法人國家衛生研究院

    財團法人國家衛生研究院
  • 財團法人食品工業發展研究所

    財團法人食品工業發展研究所
  • TFDA-衛生福利部食品藥物管理署

    TFDA-衛生福利部食品藥物管理署
  • CDE 財團法人醫藥品查驗中心

    CDE 財團法人醫藥品查驗中心
  • FDA - 美國食品藥物管理局

    FDA - 美國食品藥物管理局

04-2327-2888

E-mail : service@shineon-bio.com

Rm. B, 10F., No. 573, Sec. 2, Taiwan Blvd., West Dist., Taichung City 403020, Taiwan

NAVIGATION
  • ABOUT
  • Core Technologies
  • R&D Pipeline
  • News
  • Links
  • Investor Zone
  • Sustainable development CSR
  • Stakeholders Area
  • Contact
  • Disclaimer
  • Terms
  • Privacy
  • HOME
Copyright © 2024 - Shine-On BioMedical Web design : Newscan
TOP
LANGUAGE
  • 繁體中文
  • English
  • ABOUT
    • Overview
    • Milestone
    • Mission
    • Organization
    • Management and consulting team
  • Core Technologies
    • Targeted exosome for drug delivery
    • Trispecific T cell engager antibody
  • R&D Pipeline
    • Targeted exosome for drug delivery
      • SOB100: HLA-G targeted exosome (αHLA-G exo)
      • SOB101: HLA-G targeted exosomal doxorubicin
      • SOB102: HLA-G targeted exosomal microRNA
      • SOB201: Genetically engineered stem cell-derived exosomes
    • Trispecific T cell engager antibody
      • SOA101: Nanobody-based trispecific antibody T cell engager (Nb-TriTE)
      • SOA201: EphA10-trispecific immune cell engager antibody
    • Exosome-derived products
      • SOC101&SOC102
    • Products Pipeline
  • News
  • Links
    • 政府機構
    • 學術機構
    • 產業新知
  • Investor Zone
  • Sustainable development CSR
    • Sustainable development CSR
    • Ethics compliance and whistleblower protection
  • Stakeholders Area
  • Contact
  • Disclaimer
  • Terms
  • Privacy